Generation of TIM3 inhibitory single‑domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells
Affiliations: College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei 430070, P.R. China, Clinical Testing Branch, Hongshan District Chinese Medicine Hospital, Wuhan, Hubei 430000, P.R. China, Department of Internal Medicine‑Oncology, Hubei Cancer Hospital, Wuhan, Hubei 430079, P.R. China, Clinical Laboratory, Hospital of Huazhong Agricultural University, Wuhan, Hubei 430070, P.R. China
- Published online on: May 20, 2021 https://doi.org/10.3892/ol.2021.12803
- Article Number: 542
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.